176 related articles for article (PubMed ID: 35064101)
41. The role of angiomotin phosphorylation in the Hippo pathway during preimplantation mouse development.
Hirate Y; Sasaki H
Tissue Barriers; 2014 Jan; 2(1):e28127. PubMed ID: 24843842
[TBL] [Abstract][Full Text] [Related]
42. Differential roles of p80- and p130-angiomotin in the switch between migration and stabilization of endothelial cells.
Ernkvist M; Birot O; Sinha I; Veitonmaki N; Nyström S; Aase K; Holmgren L
Biochim Biophys Acta; 2008 Mar; 1783(3):429-37. PubMed ID: 18164266
[TBL] [Abstract][Full Text] [Related]
43. A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties.
Liu S; Sun Y; Hou Y; Yang L; Wan X; Qin Y; Liu Y; Wang R; Zhu P; Teng Y; Liu M
J Hematol Oncol; 2021 Oct; 14(1):178. PubMed ID: 34715882
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the Hippo signaling pathway.
Nandy SB; Arumugam A; Subramani R; Pedroza D; Hernandez K; Saltzstein E; Lakshmanaswamy R
Oncotarget; 2015 Jul; 6(19):17366-78. PubMed ID: 25962054
[TBL] [Abstract][Full Text] [Related]
45. Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation.
Sekido Y
Pathol Int; 2011 Jun; 61(6):331-44. PubMed ID: 21615608
[TBL] [Abstract][Full Text] [Related]
46. DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins.
Nguyen HT; Kugler JM; Cohen SM
PLoS One; 2017; 12(1):e0169587. PubMed ID: 28061504
[TBL] [Abstract][Full Text] [Related]
47. Regulation of Drosophila glial cell proliferation by Merlin-Hippo signaling.
Reddy BV; Irvine KD
Development; 2011 Dec; 138(23):5201-12. PubMed ID: 22069188
[TBL] [Abstract][Full Text] [Related]
48. Angiomotin'g YAP into the nucleus for cell proliferation and cancer development.
Hong W
Sci Signal; 2013 Sep; 6(291):pe27. PubMed ID: 24003252
[TBL] [Abstract][Full Text] [Related]
49. YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells.
White SM; Avantaggiati ML; Nemazanyy I; Di Poto C; Yang Y; Pende M; Gibney GT; Ressom HW; Field J; Atkins MB; Yi C
Dev Cell; 2019 May; 49(3):425-443.e9. PubMed ID: 31063758
[TBL] [Abstract][Full Text] [Related]
50. Loss of tricellular tight junction protein LSR promotes cell invasion and migration via upregulation of TEAD1/AREG in human endometrial cancer.
Shimada H; Abe S; Kohno T; Satohisa S; Konno T; Takahashi S; Hatakeyama T; Arimoto C; Kakuki T; Kaneko Y; Takano KI; Saito T; Kojima T
Sci Rep; 2017 Jan; 7():37049. PubMed ID: 28071680
[TBL] [Abstract][Full Text] [Related]
51. Faulty oxygen sensing disrupts angiomotin function in trophoblast cell migration and predisposes to preeclampsia.
Farrell A; Alahari S; Ermini L; Tagliaferro A; Litvack M; Post M; Caniggia I
JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996134
[TBL] [Abstract][Full Text] [Related]
52. Angiomotin promotes the malignant potential of colon cancer cells by activating the YAP-ERK/PI3K-AKT signaling pathway.
Zhang Y; Yuan J; Zhang X; Yan F; Huang M; Wang T; Zheng X; Zhang M
Oncol Rep; 2016 Dec; 36(6):3619-3626. PubMed ID: 27779692
[TBL] [Abstract][Full Text] [Related]
53. The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma.
Li J; Li Z; Wu Y; Wang Y; Wang D; Zhang W; Yuan H; Ye J; Song X; Yang J; Jiang H; Cheng J
Cell Death Dis; 2019 Aug; 10(8):603. PubMed ID: 31399556
[TBL] [Abstract][Full Text] [Related]
54. Reduced DAPK1 Expression Promotes Stem Cell-Like Characteristics of Prostate Cancer Cells by Activating ZEB1 via Hippo/YAP Signaling Pathway.
Nong S; Wei Z; Wang Z; Ma L; Guan Y; Ni J
Stem Cells Dev; 2021 Sep; 30(18):934-945. PubMed ID: 34289746
[TBL] [Abstract][Full Text] [Related]
55. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
[TBL] [Abstract][Full Text] [Related]
56. β1 integrin-dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin.
Sabra H; Brunner M; Mandati V; Wehrle-Haller B; Lallemand D; Ribba AS; Chevalier G; Guardiola P; Block MR; Bouvard D
J Biol Chem; 2017 Nov; 292(47):19179-19197. PubMed ID: 28972170
[TBL] [Abstract][Full Text] [Related]
57. Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2.
Yin F; Yu J; Zheng Y; Chen Q; Zhang N; Pan D
Cell; 2013 Sep; 154(6):1342-55. PubMed ID: 24012335
[TBL] [Abstract][Full Text] [Related]
58. Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways.
Karvonen H; Barker H; Kaleva L; Niininen W; Ungureanu D
Cells; 2019 Aug; 8(8):. PubMed ID: 31382410
[TBL] [Abstract][Full Text] [Related]
59. YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway.
Wang C; Gu C; Jeong KJ; Zhang D; Guo W; Lu Y; Ju Z; Panupinthu N; Yang JY; Gagea MM; Ng PK; Zhang F; Mills GB
Cancer Res; 2017 Apr; 77(7):1637-1648. PubMed ID: 28202507
[TBL] [Abstract][Full Text] [Related]
60. Proteolytic activation of angiomotin by DDI2 promotes angiogenesis.
Wang Y; Zhu Y; Wang Y; Chang Y; Geng F; Ma M; Gu Y; Yu A; Zhu R; Yu P; Sha Z; Qi S; Li J; Zhao W; Pan W; Zhang R; Yu FX
EMBO J; 2023 Aug; 42(15):e112900. PubMed ID: 37350545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]